Draft concept paper on the development of a reflection paper on the non-clinical development and evaluation of microbiome-based medicinal products

Human medicines European public assessment report (EPAR): Neoclarityn, desloratadine, Date of authorisation: 15/01/2001, Revision: 49, Status: Authorised

Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Azomyr, desloratadine, Date of authorisation: 15/01/2001, Revision: 55, Status: Authorised

Human medicines European public assessment report (EPAR): Aerius, desloratadine, Date of authorisation: 15/01/2001, Revision: 53, Status: Authorised

Electronic application form (eAF) Q&A clinic, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 March 2026, 11:00 (CET) to 9 March 2026, 12:00 (CET)

Human medicines European public assessment report (EPAR): Nexium Control, esomeprazole, Date of authorisation: 26/08/2013, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised

Quality of medicines: questions and answers - Part 1

Healthcare Professionals' Working Party (HCPWP) plenary meeting February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 February 2026, 09:00 (CET) to 3 February 2026, 12:10 (CET)